title: [Hepatitis B virus still under debate].
abstract: Hepatitis B is the most known viral hepatitis, and often turns into a media event in France. Its prevalence and incidence depend on countries, regions, and their inhabitants. The virus is highly infectious with a high genomic variability. Its immune reaction and pathology seem complex, but the latest consensus conferences gave a practical management. If Papillomavirus vaccine is ready and coming soon as the second STD vaccine, hepatitis B vaccine is available since 1982, and used with a real success. Fighting hepatitis B is to continue all together to immunize children and babies born from infected mothers, to adopt universal health workers precautions, to educate and modify high risk behaviours, to treat and prevent hepatitis B complications and superinfections, and finally to monitor and detect any resistant hepatitis B strain.
authors.affiliation: Service des maladies infectieuses et du voyageur, centre hospitalier de Tourcoing, 135, rue du Président-Coty, 59208 Tourcoing, France. fajana@ch-tourcoing.fr
authors.forename: F
authors.initials: F
authors.lastname: Ajana
mesh_terms: D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans
chemical_list: D017325:Hepatitis B Vaccines